- Home
- LFT vs FORA Comparison
LFT vs FORA Comparison
Compare LFT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | FORA |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Computer Software: Prepackaged Software |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 66.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LFT | FORA |
|---|---|---|
| Price | $1.42 | $2.07 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 134.0K | 14.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.68% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $20,153,263.00 |
| Revenue This Year | $124.75 | $51.82 |
| Revenue Next Year | N/A | $7.24 |
| P/E Ratio | $13.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $1.64 |
| 52 Week High | $2.84 | $2.71 |
Technical Indicators
Market Signals| Indicator | LFT | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 59.30 | 40.38 |
| Support Level | $1.41 | $2.05 |
| Resistance Level | $1.65 | $2.12 |
| Average True Range (ATR) | 0.04 | 0.02 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 96.00 | 3.00 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.